Delivery Order SPE2DB22D3501-SPE2DB23FWD07
Award Date 6/22/23
Potential Completion Date 7/14/23
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $21,827.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg on August 7, 2025, with completion scheduled for August 28, 2025. This non-set-aside award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $19,482 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 tablets of the oncology drug TIBSOVO (ivosidenib) 250 mg. To be performed in Conshohocken, Pennsylvania under contract number 4562216553, the order has a period of performance from September 18 to October 10, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's armed forces by providing supplies, transportation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a prescription medication used in oncology treatment. This competitively awarded, firm fixed-price delivery order, valued at $43,654.80, was issued on September 5, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's facilities in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $21,827.40, was competitively awarded without set-aside provisions and is scheduled for completion by May 14, 2025. The order was placed on April 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $21,827.41 to AmerisourceBergen Drug Corp for TIBSOVO 250 mg tablets (60-count units) on November 6, 2025, with completion scheduled for December 1, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $21,827.40 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Tibsovo 250 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion deadline of September 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate...
- The Defense Logistics Agency awarded a $21.8K delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tibsovo (ivosidenib) 250 mg tablets in a quantity of 60 units. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract is set to be completed by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on November 4, 2025, for TIBSOVO 250 mg tablets (60-count supply) with a firm fixed price ceiling value of $21,827.41. The contract is scheduled for completion by November 26, 2025. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $19,482 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 250 mg tablets of TIBSOVO. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 60 tablets of the specified medication to a location in Conshohocken, Pennsylvania, with performance required between July 10-31, 2023. No additional details were provided regarding major subcontractors or a potential set-aside designation. The...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $38,964.32 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 60 packages of 250 mg TIBSOVO tablets. Performance will take place in Conshohocken, Pennsylvania under a contract scheduled from August 13, 2023 through September 1, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the United States armed forces by...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWD07Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,482.16 to Amerisourcebergen Drug Corporation to supply 60 tablets of the oncology medication TIBSOVO (gilteritinib) 250mg. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning June 22, 2023 through July 14, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for cancer treatment drugs aligns with the Defense Logistics Agency's mission to provide logistics support for all military services. No subcontractors or set-aside designations were indicated.
Generated 12/20/23, 6:00 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.5k | 6/22/23 |